Español
In the last days of the year, it is time to review everything we have done so far and plan for the coming months. The year 2022 has been very special for Oligofastx, because after the start date in October 2021 and the final resolution of CDTI on December 28, 2021, the project has become […]
Monthly Archives: December 2022
22
Dec
Dec
The Oligofastx project covers all areas, from start to finish, of the process of developing oligonucleotides to fight several specific diseases: from design and preclinical research to production. Therefore, in this consortium, all the partners contribute their experience and knowledge in specific areas of action, thus completing a clear, consistent, coherent and results-oriented strategy. All […]
16
Dec
Dec
There is no doubt that oligonucleotide therapies aimed at providing answers and improving the quality of life of patients with certain rare diseases, which still have no solution, are a hopeful prospect. The path, already started with numerous initiatives, Oligofastx among them, is also a reality. But much research remains to be done, not only […]
International Biotechnology Day 2024, Uncategorized
Oligonucleotides, the language of life in small doses
12
Dec
Dec
A technological revolution can start with a key concept, the application of an equation or, often, with the development of a particular material. Steels, alloys, concretes, liquid fuels, semiconductors or polymers are examples that changed the history of mankind and today are ubiquitous in our lives. The pharmaceutical industry is no different. Thus, the ability […]